Talaris Therapeutics Inc (TALS)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
CEO:
Scott Requadt
Employees:
201 E. JEFFERSON ST., SUITE 110B, LOUISVILLE, KY 40202
502-569-1059

We are a late-clinical stage, cell therapy company developing an innovative method of allogeneic hematopoietic stem cell transplantation (allo-HSCT) that we believe has the potential to transform the standard of care in solid organ transplantation, certain severe autoimmune diseases and certain severe non-malignant blood, immune and metabolic disorders. We were initially organized as a Delaware limited liability company on February 15, 2002, under the name Regenerex LLC. On October 30, 2018, we converted to a Delaware corporation under the name of “Regenerex, Inc.” and on March 6, 2019, we changed our name to “Talaris Therapeutics, Inc.” Our principal corporate office is located in Louisville, KY

View recent insider trading info

Funds Holding TALS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TALS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

NADER FRANCOIS

  • Director
336,167 2021-12-15 1

CLARUS LIFESCIENCES III, L.P.

CLARUS VENTURES III GP, L.P.

BLACKSTONE CLARUS III L.L.C.

BLACKSTONE CLARUS GP L.P.

BLACKSTONE HOLDINGS I L.P.

BLACKSTONE HOLDINGS II L.P.

BLACKSTONE HOLDINGS I/II GP L.L.C.

BLACKSTONE GROUP INC

BLACKSTONE GROUP MANAGEMENT L.L.C.

SCHWARZMAN STEPHEN A

  • 10% Owner
8,089,315 2021-05-11 1

LONGITUDE CAPITAL PARTNERS III, LLC

LONGITUDE VENTURE PARTNERS III, L.P.

ENRIGHT PATRICK G

TAMMENOMS BAKKER JULIET

  • 10% Owner
3,220,775 2021-05-11 1

CLARUS DEFINED EXIT I, L.P.

CLARUS DE II, L.P.

CLARUS IV-A, L.P.

CLARUS IV-B, L.P.

CLARUS IV-C, L.P.

CLARUS IV-D, L.P.

CLARUS VENTURES DE GP, L.P.

CLARUS IV GP L.P.

BLACKSTONE CLARUS DE L.L.C.

BLACKSTONE CLARUS GP L.L.C.

  • 10% Owner
8,089,315 2021-05-11 1

AGARWALA SANDIP

  • Director
  • 10% Owner
3,220,775 2021-05-11 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

NADER FRANCOIS - Director by francois nader 2020 trust

2021-12-16 16:05:23 -0500 2021-12-15 G 59,520 d 336,167 indirect 17.2986 15.2449 19.6682 4 0.0 1

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
TALARIS THERAPEUTICS INC TALS 2022-01-26 22:15:03 UTC -2.0046 2.0746 1100000
TALARIS THERAPEUTICS INC TALS 2022-01-26 21:45:03 UTC -2.0046 2.0746 1100000
TALARIS THERAPEUTICS INC TALS 2022-01-26 21:15:03 UTC -2.0046 2.0746 1100000
TALARIS THERAPEUTICS INC TALS 2022-01-26 20:45:04 UTC -2.0046 2.0746 1100000
TALARIS THERAPEUTICS INC TALS 2022-01-26 20:15:03 UTC -2.0046 2.0746 1100000
TALARIS THERAPEUTICS INC TALS 2022-01-26 19:45:03 UTC -2.0046 2.0746 1100000
TALARIS THERAPEUTICS INC TALS 2022-01-26 19:15:04 UTC -2.0046 2.0746 1100000
TALARIS THERAPEUTICS INC TALS 2022-01-26 18:45:03 UTC -2.0046 2.0746 1100000
TALARIS THERAPEUTICS INC TALS 2022-01-26 18:15:04 UTC -2.0046 2.0746 1100000
TALARIS THERAPEUTICS INC TALS 2022-01-26 17:45:03 UTC -2.0046 2.0746 1100000
TALARIS THERAPEUTICS INC TALS 2022-01-26 17:15:03 UTC -2.0046 2.0746 1100000
TALARIS THERAPEUTICS INC TALS 2022-01-26 16:45:03 UTC -2.0022 2.0722 1100000
TALARIS THERAPEUTICS INC TALS 2022-01-26 16:15:03 UTC -2.0022 2.0722 1100000
TALARIS THERAPEUTICS INC TALS 2022-01-26 15:45:03 UTC -2.0022 2.0722 1100000
TALARIS THERAPEUTICS INC TALS 2022-01-26 15:15:03 UTC -2.0022 2.0722 1100000
TALARIS THERAPEUTICS INC TALS 2022-01-26 14:45:03 UTC -2.0022 2.0722 1100000
TALARIS THERAPEUTICS INC TALS 2022-01-26 14:15:04 UTC -2.0022 2.0722 1100000
TALARIS THERAPEUTICS INC TALS 2022-01-26 13:45:03 UTC -2.0022 2.0722 1100000
TALARIS THERAPEUTICS INC TALS 2022-01-26 13:15:03 UTC -2.0022 2.0722 1100000
TALARIS THERAPEUTICS INC TALS 2022-01-26 12:45:04 UTC -2.0022 2.0722 1100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments